BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 17343955)

  • 21. The guanine nucleotide exchange factor Arhgef5 plays crucial roles in Src-induced podosome formation.
    Kuroiwa M; Oneyama C; Nada S; Okada M
    J Cell Sci; 2011 May; 124(Pt 10):1726-38. PubMed ID: 21525037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.
    Varone A; Amoruso C; Monti M; Patheja M; Greco A; Auletta L; Zannetti A; Corda D
    Cell Commun Signal; 2021 Jun; 19(1):64. PubMed ID: 34088320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin.
    Liu XS; Luo HJ; Yang H; Wang L; Kong H; Jin YE; Wang F; Gu MM; Chen Z; Lu ZY; Wang ZG
    J Cell Biochem; 2007 Apr; 100(5):1288-300. PubMed ID: 17115415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cortactin-binding domain of WIP is essential for podosome formation and extracellular matrix degradation by murine dendritic cells.
    Bañón-Rodríguez I; Monypenny J; Ragazzini C; Franco A; Calle Y; Jones GE; Antón IM
    Eur J Cell Biol; 2011; 90(2-3):213-23. PubMed ID: 20952093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src-mediated phosphorylation of mammalian Abp1 (DBNL) regulates podosome rosette formation in transformed fibroblasts.
    Boateng LR; Cortesio CL; Huttenlocher A
    J Cell Sci; 2012 Mar; 125(Pt 5):1329-41. PubMed ID: 22303001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible phosphorylation of cortactin is not necessary for cortactin-mediated actin polymerisation.
    Illés A; Enyedi B; Tamás P; Balázs A; Bogel G; Buday L
    Cell Signal; 2006 Jun; 18(6):830-40. PubMed ID: 16109479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of invadopodia-like structures by synovial cells promotes cartilage breakdown in collagen-induced arthritis: involvement of the protein tyrosine kinase Src.
    Lauzier A; Charbonneau M; Harper K; Jilaveanu-Pelmus M; Dubois CM
    Arthritis Rheum; 2011 Jun; 63(6):1591-602. PubMed ID: 21337539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN.
    Han MY; Kosako H; Watanabe T; Hattori S
    Mol Cell Biol; 2007 Dec; 27(23):8190-204. PubMed ID: 17875928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation.
    Kelley LC; Ammer AG; Hayes KE; Martin KH; Machida K; Jia L; Mayer BJ; Weed SA
    J Cell Sci; 2010 Nov; 123(Pt 22):3923-32. PubMed ID: 20980387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.
    Steffen A; Le Dez G; Poincloux R; Recchi C; Nassoy P; Rottner K; Galli T; Chavrier P
    Curr Biol; 2008 Jun; 18(12):926-31. PubMed ID: 18571410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.
    Ayala I; Giacchetti G; Caldieri G; Attanasio F; Mariggiò S; Tetè S; Polishchuk R; Castronovo V; Buccione R
    Cancer Res; 2009 Feb; 69(3):747-52. PubMed ID: 19141649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
    Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
    Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
    Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
    Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
    Yoshio T; Morita T; Kimura Y; Tsujii M; Hayashi N; Sobue K
    FEBS Lett; 2007 Aug; 581(20):3777-82. PubMed ID: 17631293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion.
    Courtneidge SA; Azucena EF; Pass I; Seals DF; Tesfay L
    Cold Spring Harb Symp Quant Biol; 2005; 70():167-71. PubMed ID: 16869750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells.
    Lin YC; Tsai PH; Lin CY; Cheng CH; Lin TH; Lee KP; Huang KY; Chen SH; Hwang JJ; Kandaswami CC; Lee MT
    PLoS One; 2013; 8(8):e71903. PubMed ID: 23991004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells.
    Bertier L; Hebbrecht T; Mettepenningen E; De Wit N; Zwaenepoel O; Verhelle A; Gettemans J
    Biomed Pharmacother; 2018 Jun; 102():230-241. PubMed ID: 29567535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
    Rey M; Irondelle M; Waharte F; Lizarraga F; Chavrier P
    Eur J Cell Biol; 2011; 90(2-3):128-35. PubMed ID: 20970878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.
    Tokui N; Yoneyama MS; Hatakeyama S; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Nakamura T; Ohyama C; Tsuboi S
    Mol Med Rep; 2014 Apr; 9(4):1142-6. PubMed ID: 24549769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.